Directed toward uncovering the genetic and environmental causes of asthma and COPD, research at the Channing Laboratory — a joint effort between Brigham and Women’s Hospital and Harvard Medical School — has been the first to describe the natural history of airway responsiveness in normal and asthmatic populations, as well as the health effects of particulate air pollution and tobacco smoke exposure. Researchers at Channing Laboratory have also uncovered a gene for steroid treatment response in asthmatics on inhaled steroids.
The Channing Laboratories at Brigham and Women's Hospital